Inscription Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $441K | Sell |
5,643
-5,683
| -50% | -$458K | 0.04% | 430 |
|
|
2026
Q1 | $981K | Sell |
11,326
-856
| -7% | -$82K | 0.1% | 192 |
|
|
2025
Q4 | $1.17M | Sell |
12,182
-950
| -7% | -$92.3K | 0.12% | 157 |
|
|
2025
Q3 | $1.25M | Buy |
13,132
+4,869
| +59% | +$448K | 0.13% | 136 |
|
|
2025
Q2 | $720K | Sell |
8,263
-268
| -3% | -$22.7K | 0.1% | 140 |
|
|
2025
Q1 | $743K | Buy |
+8,531
| New | +$763K | 0.12% | 134 |
|
|
2024
Q3 | $734K | Sell |
8,157
-498
| -6% | -$41.9K | 0.11% | 142 |
|
|
2024
Q2 | $681K | Buy |
8,655
+124
| +1% | +$10.2K | 0.11% | 137 |
|
|
2024
Q1 | $743K | Buy |
8,531
+2,393
| +39% | +$204K | 0.12% | 134 |
|
|
2023
Q4 | $506K | Buy |
6,138
+772
| +14% | +$58.8K | 0.14% | 120 |
|
|
2023
Q3 | $420K | Sell |
5,366
-200
| -4% | -$16.7K | 0.14% | 117 |
|
|
2023
Q2 | $490K | Sell |
5,566
-2,212
| -28% | -$190K | 0.15% | 107 |
|
|
2023
Q1 | $627K | Sell |
7,778
-126
| -2% | -$10.3K | 0.17% | 99 |
|
|
2022
Q4 | $614K | Sell |
7,904
-2,725
| -26% | -$221K | 0.21% | 91 |
|
|
2022
Q3 | $858K | Sell |
10,629
-1,903
| -15% | -$171K | 0.24% | 73 |
|
|
2022
Q2 | $1.13M | Sell |
12,532
-1,345
| -10% | -$136K | 0.2% | 87 |
|
|
2022
Q1 | $1.55M | Sell |
13,877
-1,728
| -11% | -$183K | 0.44% | 55 |
|
|
2021
Q4 | $1.62M | Buy |
15,605
+1,531
| +11% | +$177K | 0.44% | 54 |
|
|
2021
Q3 | $1.77M | Buy |
14,074
+9,551
| +211% | +$1.24M | 0.56% | 49 |
|
|
2021
Q2 | $561K | Sell |
4,523
-10,446
| -70% | -$1.31M | 0.06% | 185 |
|
|
2021
Q1 | $1.78M | Sell |
14,969
-1,294
| -8% | -$152K | 0.61% | 47 |
|
|
2020
Q4 | $1.92M | Sell |
16,263
-5,088
| -24% | -$560K | 0.74% | 40 |
|
|
2020
Q3 | $2.23M | Sell |
21,351
-630
| -3% | -$63.3K | 0.99% | 26 |
|
|
2020
Q2 | $2.03M | Buy |
21,981
+883
| +4% | +$84.7K | 1.12% | 26 |
|
|
2020
Q1 | $1.91M | Sell |
21,098
-655
| -3% | -$69.7K | 1.27% | 21 |
|
|
2019
Q4 | $2.48M | Buy |
21,753
+3,940
| +22% | +$432K | 1.1% | 20 |
|
|
2019
Q3 | $1.94M | Buy |
17,813
+9,029
| +103% | +$942K | 1.07% | 24 |
|
|
2019
Q2 | $874K | Sell |
8,784
-2,171
| -20% | -$198K | 0.65% | 32 |
|
|
2019
Q1 | $1M | Sell |
10,955
-1,535
| -12% | -$137K | 0.53% | 37 |
|
|
2018
Q4 | $1.14M | Buy |
+12,490
| New | +$1.17M | 0.64% | 32 |
|
Other funds holding MDT
Inscription Capital's MDT Position: Q2 2026 in Review
Inscription Capital reduced its Medtronic (MDT) stake by 50% in Q2 2026, selling an estimated $458K and leaving 5,643 shares worth $441K. The position accounts for 0.04% of the portfolio, ranked #430.
Inscription Capital first reported a position in MDT in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.48M in Q4 2019. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Inscription Capital held 5,643 shares of Medtronic worth $441K as of Q2 2026.
- Inscription Capital sold 5,683 Medtronic shares in Q2 2026, an estimated $458K.
- Medtronic made up 0.04% of Inscription Capital's portfolio in Q2 2026, its #430 holding.
- Inscription Capital first reported a position in Medtronic in Q4 2018 and has held it in 30 quarters since.
- Inscription Capital's Medtronic position peaked at $2.48M in Q4 2019.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.